Aoki, S.; Ishikawa, H.; Nakajima, M.; Yamamoto, N.; Mori, S.; Omatsu, T.; Tada, Y.; Mizobuchi, T.; Ikeda, S.; Yoshino, I.;
et al. Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial Pneumonia. Cancers 2024, 16, 562.
https://doi.org/10.3390/cancers16030562
AMA Style
Aoki S, Ishikawa H, Nakajima M, Yamamoto N, Mori S, Omatsu T, Tada Y, Mizobuchi T, Ikeda S, Yoshino I,
et al. Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial Pneumonia. Cancers. 2024; 16(3):562.
https://doi.org/10.3390/cancers16030562
Chicago/Turabian Style
Aoki, Shuri, Hitoshi Ishikawa, Mio Nakajima, Naoyoshi Yamamoto, Shinichiro Mori, Tokuhiko Omatsu, Yuji Tada, Teruaki Mizobuchi, Satoshi Ikeda, Ichiro Yoshino,
and et al. 2024. "Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial Pneumonia" Cancers 16, no. 3: 562.
https://doi.org/10.3390/cancers16030562
APA Style
Aoki, S., Ishikawa, H., Nakajima, M., Yamamoto, N., Mori, S., Omatsu, T., Tada, Y., Mizobuchi, T., Ikeda, S., Yoshino, I., & Yamada, S.
(2024). Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial Pneumonia. Cancers, 16(3), 562.
https://doi.org/10.3390/cancers16030562
